Phasefocus Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 14
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 10

Phasefocus General Information

Description

Developer a disruptive lensless imaging technology designed to offer high contrast quantitative imaging and microscopy. The company's technology is used to transfer the task of image creation from a lens to a computer program, enabling users to get observation and analysis of materials, processes, and products at the nanoscale in new ways with more clarity and accuracy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Business/Productivity Software
Primary Office
  • Electric Works
  • Sheffield Digital Campus
  • Sheffield S1 2BJ
  • England, United Kingdom
+44 0114 000 0000

Phasefocus Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Phasefocus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 05-Jun-2020 000.00 Completed Generating Revenue
9. Secondary Transaction - Private 000.00 Completed Generating Revenue
8. Later Stage VC 06-Jul-2017 00.00 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 02-Jul-2012 00.000 00.000 000.00 Completed Generating Revenue
6. Grant 21-Mar-2012 00000 00.000 Completed Generating Revenue
5. Early Stage VC 05-Sep-2011 00000 00.000 Completed Generating Revenue
4. Early Stage VC 13-May-2010 00000 00.000 Completed Generating Revenue
3. Early Stage VC 17-Jul-2009 00000 00000 Completed Generating Revenue
2. Grant 01-Jan-2009 $148K $249K Completed Generating Revenue
1. Early Stage VC $249K $249K Completed Startup
To view Phasefocus’s complete valuation and funding history, request access »

Phasefocus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
A Ordinary 00 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 000 00.000000 0000 0000 00 0000 0.000
Ordinary 0,000 00.000000 0000 0000 00 0000 0.00
Ordinary 1,812 $0.128121 $106.06 $106.06 1x $106.06 1.58%
Ordinary 1,915 $0.128121 $106.03 $106.03 1x $106.03 1.67%
To view Phasefocus’s complete cap table history, request access »

Phasefocus Executive Team (5)

Name Title Board Seat Contact Info
Martin Humphry Ph.D Chief Executive Officer & Board Member
Tracey Zimmermann Vice President, Global Sales
To view Phasefocus’s complete executive team members history, request access »

Phasefocus Board Members (7)

Name Representing Role Since
Ben Edwards Phasefocus Board Member 000 0000
Ivan Shyr Self Board Observer 000 0000
Martin Humphry Ph.D Phasefocus Chief Executive Officer & Board Member 000 0000
Paul Atherton Ph.D Self Chairman 000 0000
You’re viewing 4 of 7 board members. Get the full list »

Phasefocus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phasefocus Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Braveheart Investment Group Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
Sussex Place Ventures Venture Capital Minority 000 0000 000000 0
Synergy Investments Limited Partner Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »